Ligand-independent activation of MET through IGF-1/IGF-1R signaling
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ligand-independent activation of MET through IGF-1/IGF-1R signaling
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 133, Issue 7, Pages 1536-1546
Publisher
Wiley
Online
2013-03-24
DOI
10.1002/ijc.28169
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Constitutively Activated β 1 Integrins Inhibits Prostate Cancer Metastasis
- (2013) Yu-Chen Lee et al. MOLECULAR CANCER RESEARCH
- Constitutively active c-Met kinase in PC-3 cells is autocrine-independent and can be blocked by the Met kinase inhibitor BMS-777607
- (2012) Yao Dai et al. BMC CANCER
- c-Met, epidermal growth factor receptor, and insulin-like growth factor-1 receptor are important for growth in uveal melanoma and independently contribute to migration and metastatic potential
- (2012) Xinqi Wu et al. MELANOMA RESEARCH
- The Primacy of β1 Integrin Activation in the Metastatic Cascade
- (2012) Hisashi Kato et al. PLoS One
- Combined Inhibition of IGF-1R/IR and Src Family Kinases Enhances Antitumor Effects in Prostate Cancer by Decreasing Activated Survival Pathways
- (2012) Farshid Dayyani et al. PLoS One
- Dasatinib combined with docetaxel for castration-resistant prostate cancer
- (2011) John C. Araujo et al. CANCER
- Development of c-MET pathway inhibitors
- (2011) Xiangdong Liu et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The role of HGF/c-Met signaling in prostate cancer progression and c-Met inhibitors in clinical trials
- (2011) Andreas Varkaris et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Coactivation of Receptor Tyrosine Kinases in Malignant Mesothelioma as a Rationale for Combination Targeted Therapy
- (2011) Marie Brevet et al. Journal of Thoracic Oncology
- HGF-independent potentiation of EGFR action by c-Met
- (2011) A M Dulak et al. ONCOGENE
- Stromal Hyaluronan Interaction with Epithelial CD44 Variants Promotes Prostate Cancer Invasiveness by Augmenting Expression and Function of Hepatocyte Growth Factor and Androgen Receptor
- (2010) Shibnath Ghatak et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting the HGF/c-Met Axis: State of Play
- (2010) T. A. Yap et al. MOLECULAR CANCER THERAPEUTICS
- MET signalling: principles and functions in development, organ regeneration and cancer
- (2010) Livio Trusolino et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study
- (2009) Primo N. Lara et al. ANTI-CANCER DRUGS
- Targeting of Bone-Derived Insulin-Like Growth Factor-II by a Human Neutralizing Antibody Suppresses the Growth of Prostate Cancer Cells in a Human Bone Environment
- (2009) T. Kimura et al. CLINICAL CANCER RESEARCH
- Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer
- (2009) J. P. Eder et al. CLINICAL CANCER RESEARCH
- Crosstalk in Met receptor oncogenesis
- (2009) Andrea Z. Lai et al. TRENDS IN CELL BIOLOGY
- Met Receptor Contributes to Trastuzumab Resistance of Her2-Overexpressing Breast Cancer Cells
- (2008) D. L. Shattuck et al. CANCER RESEARCH
- Targeting Src Family Kinases Inhibits Growth and Lymph Node Metastases of Prostate Cancer in an Orthotopic Nude Mouse Model
- (2008) S. I. Park et al. CANCER RESEARCH
- Transcription-Dependent Epidermal Growth Factor Receptor Activation by Hepatocyte Growth Factor
- (2008) T. E. Reznik et al. MOLECULAR CANCER RESEARCH
- Unknown
- (2008) Efstathia Papageorgiou et al. MOLECULAR MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started